Jefferies and TD Cowen started research coverage for Acadia Healthcare on September 3, 2026.
1 report, 1 independent
Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies and TD Cowen started research coverage for Acadia Healthcare on September 3, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Acadia Healthcare
multinational behavioral healthcare provider
Nothing else this week.
-
Jefferies Financial Group
American financial services company
-
TD Cowen
American investment bank
Related events
- Jefferies Financial Group boosted its price target and gave a buy rating, while TD Cowen started coverage and issued a buy rating for Voyager Technologies, Inc.
- Acadia Healthcare and Castle Biosciences are being compared as healthcare companies.
- Obsidian Therapeutics is headquartered in Cambridge, MA, and TD Cowen is providing investment banking coverage for the company.
- EyePoint Pharmaceuticals was listed on Nasdaq, accompanied by rating updates from TD Cowen (downgrade) and Jefferies (upgrade).
- TD Cowen, Stephens, Citigroup, and MarketBeat provided new analyst ratings and coverage for Covenant Logistics Group, Inc.